Kardigan, Inc. Common Stock (KARD)
PHARMACEUTICAL PREPARATIONS
- Headquarters
- United States
- Market Cap
- $1.9B
About Kardigan, Inc. Common Stock
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.
SentiSense also tracks daily options readings for Kardigan, Inc. Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Kardigan, Inc. Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.